Browsing: 409M

[ad_1] Eli Lilly bets $409M for AI-focused drug discovery [ad_2] Source: Seekingalpha

[ad_1] Eli Lilly bets $409M for AI-focused drug discovery [ad_2] Source: Seekingalpha

[ad_1] Eli Lilly bets $409M for AI-focused drug discovery [ad_2] Source: Seekingalpha

[ad_1] lcodacci Genetic Leap, an organization targeted on AI-driven drug discovery, introduced Thursday a analysis collaboration price as much as $409M with Eli Lilly (NYSE:LLY) to…